Literature DB >> 18241615

SPARCL: statin therapy for stroke patients is not crystal clear.

Robert S Rosenson.   

Abstract

Entities:  

Year:  2007        PMID： 18241615     DOI： 10.1007/s11883-007-0021-8

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  6 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions.

Authors:  Seung-Hoon Lee; Hee-Joon Bae; Byung-Woo Yoon; Ho Kim; Dong-Eog Kim; Jae-Kyu Roh
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

3.  Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program.

Authors:  K Yano; D M Reed; C J MacLean
Journal:  Stroke       Date:  1989-11       Impact factor: 7.914

Review 4.  Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis.

Authors:  Pierre Amarenco; Julien Labreuche; Philippa Lavallée; Pierre-Jean Touboul
Journal:  Stroke       Date:  2004-10-28       Impact factor: 7.914

5.  Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.

Authors:  Rory Collins; Jane Armitage; Sarah Parish; Peter Sleight; Richard Peto
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

Review 6.  Basic mechanisms of stroke prevention with lipid-lowering therapy.

Authors:  R S Rosenson
Journal:  Curr Atheroscler Rep       Date:  2000-03       Impact factor: 5.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.